Table 4

Demographic and valve characteristics of BAV patients according to aortic dilation and aorta phenotypes. Univariate and multivariate analysis

Aorta phenotypeNon-dilated aorta
168 (20.2%)
Dilated aorta
663 (79.8%)
Aortic root
77 (45.8%)
Ascending aorta
91 (54.2%)
p ValueAortic root
122 (18.4%)
Ascending aorta
541 (81.6%)
p Value
Univariate analysis
Demographics and clinical data
Age, years 42.1±17.449.2±14.50.06641.5±16.949.2±16.60.0001
Male, n (%)58 (75.3)61 (67.0)0.307106 (86.9)363 (67.1)0.0001
Smoking, n (%)15 (19.4)28 (31.0)0.13932 (26.4)163 (30.1)0.502
Hypertension, n (%)15 (19.4)27 (27.2)0.09932 (26.4)185 (34.2)0.009
Diabetes mellitus, n (%)3 (4.8)10 (11.1)0.1434 (3.3)27 (5.2)0.511
Dyslipidaemia, n (%)13 (17.3)22 (24.1)0.33220 (16.5)130 (24.0)0.074
Valve morphotype
0.0060.001
BAV-RL, n (%)54 (77.1)45 (49.4)101 (83.0)385 (71.1)
BAV-RN, n (%)13 (18.6)36 (40.1)10 (8.2)135 (25.1)
BAV-LN, n (%)3 (4.3)2 (2.2)7 (5.7)12 (2.2)
Valve abnormality and function
Raphe, n (%)57 (74.0)64 (70.3)0.48692 (75.4)429 (79.3)0.362
Sigmoid prolapse, n (%)7 (9.1)9 (9.9)0.99923 (18.9)71 (13.1)0.112
Non-significant valve dysfunction, n (%)58 (75.3)58 (63.7)0.10565 (53.3)266 (49.2)0.001
AS dominant, n (%)6 (7.8)23 (25.3)7 (5.7)148 (27.4)
AR dominant, n (%)13 (16.9)10 (11.0)50 (41.0)127 (23.5)